ROS1 FUSION GENES: POTENTIAL DRUG TARGETS IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Davies, Kurtis D. [1 ]
Le, Anh T. [1 ]
Theodoro, Mariana F. [1 ]
Skokan, Margaret C. [1 ]
Aisner, Dara L. [2 ]
Terracciano, Luigi M. [3 ]
Incarbone, Matteo [4 ]
Roncalli, Massimo [4 ]
Cappuzzo, Federico [5 ]
Camidge, Ross D. [1 ]
Doebele, Robert C. [1 ]
Garcia, Marileila V. [1 ]
机构：
[1] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA
[2] Univ Colorado, Sch Med, Dept Pathol, Boulder, CO 80309 USA
[3] Univ Basel Hosp, Basel, Switzerland
[4] Ist Clin Humanitas, Rozzano, Italy
[5] Livorno Hosp, Livorno, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [1] Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
    Gainor, Justin F.
    Shaw, Alice T.
    ONCOLOGIST, 2013, 18 (07): : 865 - 875
  • [2] The landscape of ROS1 fusion in patients with non-small cell lung cancer in China
    Chen, M.
    Huang, D.
    She, X.
    Shen, X.
    Zhang, H.
    Luo, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S891 - S891
  • [3] Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer
    Zhang, Qing
    Wu, Chunyan
    Ding, Wei
    Zhang, Zhihong
    Qiu, Xueshan
    Mu, Dianbin
    Zhang, Haiqing
    Xi, Yanfeng
    Zhou, Jianhua
    Ma, Liheng
    Fu, Shijun
    Gao, Min
    Wang, Bo
    Deng, Juan
    Lin, Dongmei
    Zhang, Jie
    THORACIC CANCER, 2019, 10 (01) : 47 - 53
  • [4] The routine detection of ROS1 fusion rearrangement in non-small cell lung cancer
    Wu, J.
    Lin, Y.
    He, X.
    He, P.
    Fu, X.
    Gu, X.
    ANNALS OF ONCOLOGY, 2015, 26 : 9 - 9
  • [5] Zeroing in on ROS1 Rearrangements in Non-Small Cell Lung Cancer
    Stumpfova, Magda
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4222 - 4224
  • [6] Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
    Itchins, M.
    Alexander, M.
    John, T.
    Kao, S.
    Hughes, B.
    Hayes, S.
    Howel, V.
    Harvie, R.
    Clarke, S.
    Millward, M.
    Pavlakis, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S684 - S684
  • [7] Clinicopathological significance and diagnostic approach of ROS1 rearrangement in non-small cell lung cancer: a meta-analysis: ROS1 in non-small cell lung cancer
    Yang, Jungho
    Pyo, Jung-Soo
    Kang, Guhyun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04): : 520 - 527
  • [8] Resistance to lorlatinib in ROS1 fusion-positive non-small cell lung cancer.
    Lin, Jessica Jiyeong
    Johnson, Ted
    Lennerz, Jochen K.
    Lee, Charlotte
    Hubbeling, Harper Grace
    Yeap, Beow Y.
    Dagogo-Jack, Ibiayi
    Gainor, Justin F.
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Importance of ROS1 gene fusions in non-small cell lung cancer
    Muminovic, Meri
    Uribe, Carlos Rodrigo Carracedo
    Alvarez-Pinzon, Andres
    Shan, Khine
    Raez, Luis E.
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 332 - 344
  • [10] ROS1 positive Non-Small Cell Lung Cancer clinical case
    Silva, Sonia
    Feijo, Salvato
    MEDICINE, 2020, 99 (23)
12345